MO
Molecular Partners AG
MOLN · NASDAQ
$4.21 +4.73% (+$0.19)
1M -4.32%
Market Cap CHF 129.9M
P/E Ratio -
Div. Yield -
ROE 65.62%
Bulios Fair Price
$2.32
44.9% downside
Trenutna cena
$4.21
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MOLN trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
90 /100
Cheap P/B 1.90x
P/E N/A
P/FFO N/A
Growth
0 /100
Declining Book val. growth 30.09%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 72.64%
Asset turnover 0.00x
ROE 65.62%
Debt
69 /100
Low Debt/Equity 0.05x
Int. coverage -1,954.60x
Current ratio 9.42x
Stability
28 /100
Unstable Beta 0.69x
Profitable years 0
Rev. volatility 39.74%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MOLN
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Patrick Amstutz
Employees
134
Headquarters
Schlieren
Prihajajoči dogodki
29 OKT.
Earnings
Upcoming earnings report